The PNPLA3 I148M variant has been shown to have a positive association with hepatic fat content (steatosis), NAFLD, non-alcoholic steatohepatitis (NASH) as well as hepatocellular carcinoma (Dong, 2019). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.